Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Nebraska
Adela, Inc
Case Comprehensive Cancer Center
Arcus Biosciences, Inc.
Universidade Federal de Pernambuco
Taproot Health
Shenzhen BinDeBio Ltd.
Ohio State University Comprehensive Cancer Center
Shenzhen Second People's Hospital
Celldex Therapeutics
Stanford University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center